SCROLL DOWN TO VIEW VIDEOS
Life-changing improvements 26 years after TBI following a single treatment by Edward Tobinick, M.D.
Life-changing Improvements, including improvements in vision, chronic pain, motor control, balance, and swallowing after a single dose of perispinal etanercept (PSE), given 26 years after a car crash causing severe traumatic brain injury.
Filmed August 4, 2022, at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
So many improvements following stroke treatment by Dr. Tobinick
“This has changed our lives big time.” Improvements in post-stroke pain, post-stroke fatigue, balance, cognition, speech, swallowing, and spasticity. Perispinal etanercept treatment by Edward Tobinick, M.D. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on April 26, 2022.
Request a consultation today | Terms of Use & Disclaimer
Dramatic relief of chronic stroke pain after treatment by Edward Tobinick, M.D.
Dramatic relief of chronic stroke pain after treatment by Dr. Tobinick. Additional improvements in speech, vision, and swallowing. Filmed March 9, 2022, 2 years 7 months after stroke, at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Request a consultation today | Terms of Use & Disclaimer
Speech and hand function improve 4 years after stroke following treatment by Edward Tobinick, M.D.
Rapid and sustained improvement in speech, ability to walk, hand function, foot pain, spasticity, range of motion and swallowing following PSE treatment by Dr. Tobinick. Treatment was given more than 3 years after the stroke occurred.
Text, images and video © 2021, INR PLLC, all rights reserved.
Request a consultation today | Terms of Use & Disclaimer
Walking without a cane 10 months after stroke after treatment by Edward Tobinick, M.D.
Walking without a cane 10 months after stroke, with less fatigue, and improvements in cognition and swallowing following treatment by Dr. Tobinick on December 16, 2020, at the INR in Boca Raton, Florida.
Text, images and video © 2021, INR PLLC, all rights reserved.
Request a consultation today | Terms of Use & Disclaimer
4 years after brainstem stroke, improvements in chronic central post-stroke pain and less difficulty in swallowing immediately following PSE treatment by Dr. Tobinick, February 28, 2020.
Text, images and video © 2020, INR PLLC, all rights reserved.
Request a consultation today | Terms of Use & Disclaimer
Immediate improvements 2 years after brainstem stroke. Treatment by Edward Tobinick, M.D., 1/30/20
PSE treatment by Dr. Tobinick. Improvements in pain, swallowing, vision, and breathing. Filmed at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida, on January 30, 2020.
Request a consultation today | Terms of Use & Disclaimer
Many Rapid Improvements 2 years after Stroke, from Iceland to the INR, March 9, 2018
Patient and father, from Iceland, discusses improvements 2 years after stroke. The stroke happened at age 17. Improvements discussed include: spasticity, left neglect, walking, speech, fatigue, and improved ability to swallow.
Request a consultation today | Terms of Use & Disclaimer
Speech & Hand Function Improvement after PSE Treatment 3.5 Years After Stroke
Patient from Brazil speaks of his speech and hand function improvement after PSE treatment 3 1/2 years after his stroke at INR in Boca Raton, Florida in July 2015. Text, images and video © 2019, INR PLLC, all rights reserved.
Request a consultation today | Terms of Use & Disclaimer
A new patented scientific discovery by the INR, as documented in the videos above, now promises to change current thinking about the potential for recovery after stroke or brain injury, even years later.
Exemplary Literature Reference:
- Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, Depuy V. Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury: An Observational Study Involving 629 Consecutive Patients Treated with PSE. CNS Drugs. 2012;26(12):1051-70.